Cross-priming in health and disease
- PMID: 20498667
- DOI: 10.1038/nri2780
Cross-priming in health and disease
Abstract
Cross-priming is an important mechanism to activate cytotoxic T lymphocytes (CTLs) for immune defence against viruses and tumours. Although it was discovered more than 25 years ago, we have only recently gained insight into the underlying cellular and molecular mechanisms, and we are just beginning to understand its physiological importance in health and disease. Here we summarize current concepts on the cross-talk between the immune cells involved in CTL cross-priming and on its role in antimicrobial and antitumour defence, as well as in immune-mediated diseases.
Similar articles
-
Molecular mechanisms and biological significance of CTL avidity.Curr HIV Res. 2003 Jul;1(3):287-94. doi: 10.2174/1570162033485230. Curr HIV Res. 2003. PMID: 15046253 Review.
-
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?Front Immunol. 2018 Dec 13;9:2874. doi: 10.3389/fimmu.2018.02874. eCollection 2018. Front Immunol. 2018. PMID: 30619259 Free PMC article. Review.
-
Toll-like receptor 3 promotes cross-priming to virus-infected cells.Nature. 2005 Feb 24;433(7028):887-92. doi: 10.1038/nature03326. Epub 2005 Feb 13. Nature. 2005. PMID: 15711573
-
CD4+ T cell help in cancer immunology and immunotherapy.Nat Rev Immunol. 2018 Oct;18(10):635-647. doi: 10.1038/s41577-018-0044-0. Nat Rev Immunol. 2018. PMID: 30057419 Review.
-
The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes.Vaccine. 2010 Dec 6;28(52):8280-7. doi: 10.1016/j.vaccine.2010.10.007. Epub 2010 Oct 19. Vaccine. 2010. PMID: 20965298
Cited by
-
Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8⁺ T cell priming.PLoS One. 2012;7(12):e51845. doi: 10.1371/journal.pone.0051845. Epub 2012 Dec 18. PLoS One. 2012. PMID: 23272178 Free PMC article.
-
Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy.Oncogene. 2017 Feb 2;36(5):585-592. doi: 10.1038/onc.2016.231. Epub 2016 Jul 18. Oncogene. 2017. PMID: 27425593 Free PMC article. Review.
-
A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection.Front Immunol. 2019 Sep 12;10:2161. doi: 10.3389/fimmu.2019.02161. eCollection 2019. Front Immunol. 2019. PMID: 31572376 Free PMC article.
-
Physical activation of innate immunity by spiky particles.Nat Nanotechnol. 2018 Nov;13(11):1078-1086. doi: 10.1038/s41565-018-0274-0. Epub 2018 Oct 29. Nat Nanotechnol. 2018. PMID: 30374159 Free PMC article.
-
Induction of Apoptosis in Toxoplasma gondii Infected Hela Cells by Cisplatin and Sodium Azide and Isolation of Apoptotic Bodies and Potential Use for Vaccination against Toxoplasma gondii.Iran J Parasitol. 2018 Jul-Sep;13(3):406-415. Iran J Parasitol. 2018. PMID: 30483332 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources